Tilray Brands (TLRY) Shares Outstanding (2017 - 2026)
Tilray Brands' (TLRY) quarterly Shares Outstanding (Entity) came in at $131.7 million in Q2 2026, up 24.15% YoY from $106.1 million in Q2 2025, and up 12.99% on a QoQ basis from $116.5 million in Q1 2026.
Tilray Brands (TLRY) Shares Outstanding (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Shares Outstanding (Entity) data on file, last reported at $131.7 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 24.15% year-over-year to $131.7 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $131.7 million (up 24.15% YoY) and the FY2026 annual result came in at $131.7 million, up 24.15% from the prior year.
- Shares Outstanding (Entity) improved to $131.7 million in Q2 2026, from $116.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $131.7 million in Q2 2026 to a low of $48.1 million in Q1 2022.
- A 5-year average of $84.3 million and a median of $80.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 97.62% — and 2026, when it climbed 18.52%.
- Tracing TLRY's Shares Outstanding (Entity) over 5 years: stood at $61.3 million in 2022, then advanced by 19.53% to $73.3 million in 2023, then grew by 26.79% to $92.9 million in 2024, then rose by 25.39% to $116.5 million in 2025, then gained by 13.01% to $131.7 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $131.7 million (Q2 2026), $116.5 million (Q1 2026), and $116.5 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 111.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 111.83 Mn |
| Feb 28, 2026 | 112.68 Mn |
| Nov 30, 2025 | 110.34 Mn |
| Aug 31, 2025 | 106.03 Mn |
| May 31, 2025 | 89.03 Mn |
| Feb 28, 2025 | 90.83 Mn |
| Nov 30, 2024 | 86.50 Mn |
| Aug 31, 2024 | 87.54 Mn |
| May 31, 2024 | 74.26 Mn |
| Feb 29, 2024 | 75.44 Mn |
| Nov 30, 2023 | 73.08 Mn |
| Aug 31, 2023 | 69.12 Mn |
| May 31, 2023 | 61.80 Mn |
| Feb 28, 2023 | 61.55 Mn |
| Nov 30, 2022 | 61.17 Mn |
| Aug 31, 2022 | 57.53 Mn |
| May 31, 2022 | 48.12 Mn |
| Feb 28, 2022 | 48.57 Mn |
| Nov 30, 2021 | 46.03 Mn |
| Aug 31, 2021 | 44.94 Mn |